[Editorial] Are adolescent and young adult cancer patients affected by ‘chemobrain’?: A call for evidence
Chan, Alexandre, Ng, Terence, Chan, Raymond Javan, Poon, Eileen, & Mohamad, Farid (2016) [Editorial] Are adolescent and young adult cancer patients affected by ‘chemobrain’?: A call for evidence. Expert Review of Quality of Life in Cancer Care, 1(3), pp. 187-188.
Administrators only until November 2017 | Request a copy from author
An adolescent and young adult (AYA) cancer patient is defined as an individual of 15 to 39 years of age at the time of initial cancer diagnosis.1,2 The number of AYA cancer survivors has dramatically increased over the past decades due to availability of novel therapeutics, with the 5-year overall survival rate among adolescents aged 15 to 19 years old exceeds 80% for most cancers.3 AYA cancer survivors, however, often experience a myriad of treatment-related chronic and late toxicities that can lead to functional impairment at great economic, emotional and social cost.4 As the cure rates of AYA cancers continue to improve and survivors live longer, post-treatment health issues in these survivors are becoming increasingly relevant, and more in-depth research is needed in this group of patients...
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Cognitive Impairment, Adolescent and Young Adult, Survivorship, Cancer, Quality of life, Chemobrain|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > NURSING (111000)
Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200)
|Divisions:||Current > Institutes > Institute of Health and Biomedical Innovation|
|Copyright Owner:||Copyright 2016 Taylor & Francis|
|Deposited On:||05 May 2016 22:48|
|Last Modified:||17 Jun 2016 03:13|
Repository Staff Only: item control page